albendazole has been researched along with enbucrilate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sun, DJ; Wang, GQ; Wen, H; Zhang, Q; Zhang, XN | 1 |
| Akhan, O; Canyigit, M; Cay, N; Erol, B; Gumus, M; Karaoglanoglu, M | 1 |
2 other study(ies) available for albendazole and enbucrilate
| Article | Year |
|---|---|
[Preparation of albendazole polybutycyanocrylate nanoparticles and study on its pharmaceutical properties and tissue distribution].
Topics: Albendazole; Animals; Anthelmintics; Biological Availability; Drug Carriers; Drug Delivery Systems; Enbucrilate; Female; Liver; Male; Mice; Nanotechnology; Particle Size; Spleen; Technology, Pharmaceutical; Tissue Distribution | 2003 |
Refractory cystobiliary fistula secondary to percutaneous treatment of hydatid cyst: treatment with N-butyl 2-cyanoacrylate embolization.
Topics: Adult; Albendazole; Anticestodal Agents; Biliary Fistula; Combined Modality Therapy; Drainage; Echinococcosis, Hepatic; Embolization, Therapeutic; Enbucrilate; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Tissue Adhesives; Tomography, Spiral Computed; Ultrasonography | 2011 |